Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study.
Javier Rueda-GotorRaquel López-MejíasSara Remuzgo-MartínezVerónica Pulito-CuetoAlfonso CorralesLeticia Lera-GómezVirginia PortillaÍñigo González-MazónRicardo BlancoRosa ExpósitoCristina MataJavier LlorcaVanesa Hernández-HernándezCarlos Rodríguez-LozanoNuria BarbarrojaRafaela Ortega CastroEsther VicenteCristina Fernández-CarballidoMaría Paz Martínez-VidalDavid Castro-CorredorJoaquín Anino-FernándezDiana PeiteadoChamaida Plasencia-RodríguezEva Galíndez-AgirregoikoaMaría Luz García-VivarOreste GualilloJuan Carlos Quevedo-AbeledoSantos CastañedaIván Ferraz-AmaroMiguel Á González-GayFernanda GenrePublished in: Arthritis research & therapy (2021)
Our results revealed that vaspin is linked to CV risk factors that may influence on the atherosclerotic process in axSpA. Additionally, we disclosed that serum vaspin concentration is genetically modulated in a large cohort of patients with axSpA.